Edition:
United Kingdom

Seres Therapeutics Inc (MCRB.OQ)

MCRB.OQ on NASDAQ Stock Exchange Global Select Market

8.10USD
14 Aug 2018
Change (% chg)

$0.10 (+1.25%)
Prev Close
$8.00
Open
$8.00
Day's High
$8.12
Day's Low
$7.90
Volume
14,344
Avg. Vol
45,267
52-wk High
$17.33
52-wk Low
$6.65

Chart for

About

Seres Therapeutics, Inc. is a microbiome therapeutics platform company. The Company is engaged in developing a class of biological drugs, which is referred as Ecobiotic microbiome therapeutics. The Company's drugs are designed to restore health by repairing the function of a dysbiotic microbiome. The Company is focused on... (more)

Overall

Beta: --
Market Cap(Mil.): $482.91
Shares Outstanding(Mil.): 40.51
Dividend: --
Yield (%): --

Financials

  MCRB.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -2.42 -- --
ROI: -41.51 1.78 14.61
ROE: -76.34 3.28 16.33

BRIEF-Seres Therapeutics Reports Qtrly Loss Per Share Of $0.69

* SERES THERAPEUTICS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES OPERATIONAL UPDATES

09 May 2018

BRIEF-Nestle Health Science Us Holdings, Inc Reports 16.97 Pct Stake In Seres Therapeutics Inc

* Nestle Health Science Us Holdings, Inc Reports 16.97 Pct Stake In Seres Therapeutics Inc As Of April 10, 2018 - SEC Filing Source text (https://bit.ly/2GSzKlq) Further company coverage: (Reuters.Briefs@thomsonreuters.com)

11 Apr 2018

BRIEF-Seres Therapeutics Qtrly Net Loss Of $29.0 Mln Vs $25.3 Mln

* SERES THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

08 Mar 2018

Earnings vs. Estimates